sever
acut
respiratori
syndrom
sar
newli
emerg
diseas
first
emerg
guangdong
provinc
china
novemb
sar
coronaviru
sarscov
found
etiolog
diseas
subsequ
surveil
studi
indic
viru
anim
origin
suggest
sourc
diseas
still
circul
geograph
region
inde
potenti
risk
reemerg
sar
highlight
recent
confirm
sar
case
januari
therefor
establish
rapid
sar
diagnost
method
high
prioriti
control
diseas
current
two
major
diagnost
approach
sar
detect
antibodi
sarscov
sensit
specif
diagnost
approach
serconvers
detect
around
day
ill
contrast
pcrbase
test
shown
use
earli
sar
diagnosi
quantit
pcr
approach
power
tool
identifi
sarscov
earli
diseas
onset
howev
requir
sophist
instrument
expens
reagent
rapid
molecular
test
might
method
choic
basic
clinic
set
develop
countri
field
situat
therefor
critic
develop
simpl
econom
molecular
test
scenario
invent
loopmedi
isotherm
amplif
lamp
open
new
horizon
molecular
diagnosi
method
depend
autocycl
strand
displac
dna
synthesi
perform
bst
dna
polymeras
detail
amplif
mechan
describ
elsewher
reaction
reli
recognit
dna
target
six
independ
sequenc
make
kind
assay
highli
specif
method
rapid
dna
amplif
effici
equival
pcrbase
method
importantli
approach
inexpens
reaction
perform
isotherm
environ
potenti
clinic
applic
method
demonstr
recent
demonstr
feasibl
use
technolog
detect
sarscov
thirtyon
retrospect
sar
sampl
collect
march
april
use
studi
sar
patient
studi
confirm
seroposit
sarscov
immunofluoresc
assay
age
rang
patient
year
median
year
f
ratio
studi
approv
local
clinic
research
ethic
committe
nasopharyng
aspir
npa
sampl
collect
day
diseas
onset
describ
previous
npa
sampl
patient
respiratori
diseas
adenoviru
n
respiratori
syncyti
viru
n
human
metapneumoviru
n
influenza
viru
n
influenza
b
viru
n
rhinoviru
n
healthi
individu
n
use
neg
control
rna
clinic
sampl
extract
cdna
synthes
describ
previous
studi
region
sarscov
nucleotid
access
see
reaction
mixtur
incub
h
follow
heat
inactiv
min
amplifi
product
analyz
gel
electrophoresi
preliminari
experi
reaction
perform
differ
copi
number
posit
control
determin
detect
limit
assay
reaction
product
consist
stemloop
dna
structur
multipl
invert
repeat
target
cauliflowerlik
structur
multipl
loopstemloop
reaction
would
produc
band
differ
size
gel
electrophoresi
analys
shown
fig
characterist
dna
ladder
observ
posit
control
lane
detect
limit
assay
copiesreact
see
fig
onlin
data
supplement
posit
signal
consist
observ
reaction
contain
copi
target
sequenc
data
shown
among
sar
sampl
sarscov
sequenc
could
detect
case
fig
lane
detect
rate
sarscov
sampl
increas
diseas
progress
tabl
earli
stage
diseas
onset
posit
assay
technic
brief
sampl
isol
day
day
diseas
onset
posit
signal
observ
case
n
result
agre
previou
find
viral
load
sar
patient
peak
second
week
diseas
target
sequenc
contain
bglii
xbai
restrict
site
see
fig
onlin
data
supplement
also
valid
ident
posit
signal
restrict
enzym
digest
amplifi
product
could
digest
restrict
enzym
expect
fig
onlin
data
supplement
fig
contrast
posit
signal
observ
healthi
individu
n
data
shown
nonsar
patient
n
fig
lane
water
control
fig
lane
studi
demonstr
potenti
use
lamp
earli
sar
diagnosi
recent
also
report
use
quantit
pcr
method
sar
diagnosi
compar
quantit
pcr
assay
lamp
assay
describ
studi
two
main
shortcom
lamp
assay
allow
quantif
sarscov
rna
b
lamp
assay
less
sensit
realtim
pcr
assay
howev
one
note
detect
rate
sar
lamp
assay
tabl
similar
convent
pcrbase
assay
confirm
observ
test
clinic
sampl
convent
pcr
assay
shown
tabl
detect
rate
lamp
assay
similar
revers
transcriptionpcr
assay
result
agre
previou
find
sensit
lamp
assay
equival
convent
pcrbase
method
lamp
reaction
reli
recognit
viral
sequenc
six
primer
potenti
make
kind
assay
specif
convent
pcr
assay
inde
none
neg
control
sampl
n
posit
assay
recent
parida
et
al
report
realtim
closedtub
detect
method
west
nile
viru
amount
magnesium
pyrophosph
precipit
gener
lamp
reaction
measur
realtim
approach
lamp
might
reduc
risk
crosscontamin
problem
primari
goal
studi
develop
simpl
inexpens
test
sar
diagnosi
unlik
quantit
pcrbase
detect
approach
lamp
assay
requir
sophist
instrument
reaction
perform
isotherm
environ
eg
water
bath
time
loss
thermal
chang
dna
amplif
lamp
assay
rapid
requir
expens
reagent
conclus
report
simpl
lamp
assay
sar
diagnosi
believ
inexpens
run
cost
assay
make
technolog
applic
laboratori
sar
diagnosi
develop
countri
techniqu
might
great
potenti
use
field
situat
bedsid
preliminari
screen
test
regardless
method
use
test
suitabl
accredit
laboratori
import
especi
outbreak
qualityassur
diagnos
essenti
expect
rapid
diagnost
method
prompt
identif
pathogen
facilit
control
diseas
provis
prompt
treatment
patient
microalbuminuria
mau
defin
urinari
albumin
excret
mgday
indic
high
probabl
renal
damag
accept
predictor
earli
diagnosi
nephropathi
diabet
patient
addit
mau
diagnost
implic
pregnanc
predict
marker
preeclampsia
may
play
role
identifi
high
risk
develop
complic
cardiovascular
diseas
even
nondiabet
patient
dyebind
assay
measur
serum
albumin
insensit
mau
test
make
immunochem
assay
wide
use
mau
method
immunoassay
includ
immunoturbidimetri
immunofluoresc
elisa
ria
zone
immunoelectrophoresi
recent
kessler
cowork
introduc
laserinduc
fluoresc
system
coupl
autom
centrifug
analyz
nonimmunolog
assay
urinari
albumin
system
base
probe
albumin
blue
becom
highli
fluoresc
bind
albumin
report
fluoresc
immunochromatographi
technic
brief
